Shares of Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) traded up 3.8% during trading on Tuesday . The stock traded as high as GBX 51.90 and last traded at GBX 51.90. 59,455 shares were traded during trading, a decline of 18% from the average session volume of 72,176 shares. The stock had previously closed at GBX 50.
Beximco Pharmaceuticals Trading Down 6.7%
The stock has a market capitalization of £208.22 million, a P/E ratio of 0.03 and a beta of 0.61. The stock’s fifty day moving average price is GBX 42.86 and its two-hundred day moving average price is GBX 42.70. The company has a current ratio of 4.13, a quick ratio of 0.37 and a debt-to-equity ratio of 5.27.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Recommended Stories
- Five stocks we like better than Beximco Pharmaceuticals
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
